Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility of the "Paso a Paso" Weight Loss Program for Mexican & Central American Patients With Metabolic Dysfunction Associated Steatotic Liver Disease(MASLD)

NCT06854185 is registered in ClinicalTrials.gov with Baylor College of Medicine as lead sponsor.

NCT NCT06854185
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06854185 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility of the "Paso a Paso" Weight Loss Program for Mexican & Central American Patients With Metabolic Dysfunction Associated Steatotic Liver Disease(MASLD)
Lead sponsor
Baylor College of Medicine
Phase
Not applicable
Overall status
Active, not recruiting
Start date
February 5, 2025
Completion date
December 31, 2026
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic dysfunction associated steatotic liver disease, metabolic syndrome, overweight (bmi > 25)